Evidence map›Paper›PMID 19784808›Full record

ArticleCellular and molecular life sciences : CMLS2009

Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.

Sreelatha Gopinath, Sravan K Vanamala, Meena Gujrati, Jeffrey D Klopfenstein, Dzung H Dinh, Jasti S Rao

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sreelatha GopinathDepartment of Cancer Biology and Pharmacology, College of Medicine at Peoria, University of Illinois, 1649 Peoria, IL 61656, USA.
Sravan K Vanamala
Meena Gujrati
Jeffrey D Klopfenstein
Dzung H Dinh
Jasti S Rao
Peoria campus of the University of Illinois System · US

Funding

Cath B and uPAR si RNA constructs regressed glioma growthR01CA116708 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI O'BRYAN, JOHN P · 2005 to 2014
$2.9M
Role of uPA and uPAR in Human Glioma InvasivenessR01CA075557 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI RAO, JASTI S. · 1998 to 2009
$2.3M
Inhibition of matrix proteases to sensitize medulloblastoma cells to radiationR01CA138409 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GARTEL, ANDREI L · 2009 to 2013
$1.6M
NCI NIH HHS CA116708NCI NIH HHS CA138409NCI NIH HHS CA75557NCI NIH HHS R01 CA075557NCI NIH HHS R01 CA116708NCI NIH HHS R01 CA138409
6 · The paper itself

Abstract

Nuclear factor of activated T cells (NFAT), a family of transcription factors, has been implicated in many cellular processes, including some cancers. Here, we characterize, for the first time, the role of NFAT3 in doxorubicin (DOX)-mediated apoptosis, migration, and invasion in SNB19 and U87 glioma cells. This study demonstrates that the specific knockdown of NFAT3 results in a dramatic inhibition of the apoptotic effect induced by DOX and favors cell survival. Inhibition of NFAT3 activation by shNFAT3 (shNF3) significantly downregulated tumor necrosis factor (TNF)-alpha induction, its receptor TNFR1, caspase 10, caspase 3, and poly (ADP-ribose) polymerase, abrogating DOX-mediated apoptosis in glioma cells. DOX treatment resulted in NFAT3 translocation to the nucleus. Similarly, shNF3 treatment in SNB19 and U87 cells reversed DOX-induced inhibition of cell migration and invasion, as determined by wound healing and matrigel invasion assays. Taken together, these results indicate that NFAT3 is a prerequisite for the induction of DOX-mediated apoptosis in glioma cells.

Indexed as

Active Transport, Cell NucleusAntibiotics, AntineoplasticApoptosisBlotting, WesternCaspase 10Caspase 3Cell Line, TumorCell MovementCell NucleusCell SurvivalDoxorubicinFlow CytometryFluorescent Antibody TechniqueG1 PhaseGliomaHumansAntibiotics, AntineoplasticCaspase 10Caspase 3DoxorubicinNFATC Transcription FactorsPoly(ADP-ribose) PolymerasesReceptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alpha

Identifiers

PMID19784808
PMCPMC2809824
OpenAlexW2089193351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.